[SCHEDULE 13G] Charles River Laboratories International, Inc. SEC Filing

Rhea-AI Filing Summary

Nomura Holdings, Inc. reports beneficial ownership of 2,681,669 shares of Charles River Laboratories common stock, representing 5.4% of the outstanding class. The total includes 473,087 shares held by Nomura Global Financial Products, Inc. (NGFP), 1,096,182 shares held by Nomura Securities International, Inc. (NSI), and call options exercisable within 60 days covering 1,112,400 shares (1,100,000 by NGFP and 12,400 by NSI). The percent is calculated using 49,209,000 shares outstanding as of June 28, 2025, per the issuer's quarterly report. The filing states these holdings were acquired and are held in the ordinary course of business.

Positive

• Nomura Holdings reports a material stake of 2,681,669 shares (5.4%)
• Includes call options exercisable within 60 days covering 1,112,400 shares

Negative

• None.

Insights

Financial Analyst

TL;DR: A global financial group holds a >5% stake, including exercisable calls, which is material to shareholder composition.

Nomura Holdings' reported 5.4% position in Charles River is large enough to be noticed by the market and other investors. The position combines outright shares and call options exercisable within 60 days, effectively increasing near-term potential ownership. For valuation or takeover scenarios, the presence of options matters because they can convert into voting shares soon, modestly increasing Nomura's influence. The filing indicates holdings are held in the ordinary course of business, not expressly for control purposes.

Corporate Governance Expert

TL;DR: Disclosure of a >5% holder triggers governance monitoring but does not itself indicate activism.

The Schedule 13G classification and the certification that the securities are held in the ordinary course of business suggest Nomura does not intend to change or influence control. Still, crossing the 5% threshold requires increased transparency and may prompt the issuer and other large shareholders to monitor Nomura's stake and any subsequent filings. The filing references subsidiaries NGFP and NSI and attaches subsidiary identification in an exhibit, aligning with typical parent-subsidiary reporting practices.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

159864107

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 159864107

1

Names of Reporting Persons

NOMURA HOLDINGS INC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

JAPAN

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,681,669.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,681,669.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,681,669.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: (1) Sole voting and dispositive power represents (i) 473,087 shares of Common Stock beneficially owned by Nomura Global Financial Products, Inc. ("NGFP"), (ii) 1,100,000 shares of Common Stock underlying call options beneficially owned by NGFP that are exercisable within 60 days, (iii) 1,096,182 shares of Common Stock beneficially owned by Nomura Securities International, Inc. ("NSI"), and (iv) 12,400 shares of Common Stock underlying call options beneficially owned by NSI that are exercisable within 60 days. NGFP and NSI are wholly owned subsidiaries of Nomura Holdings, Inc., which accordingly may be deemed to beneficially own the shares of Common Stock beneficially owned by NGFP and NSI. (2) The percent of class is calculated based on 49,209,000 shares of Common Stock outstanding as of June 28, 2025, as reported in the Issuer's quarterly report on Form 10-Q for the fiscal quarter ended June 28, 2025 filed with the SEC on August 6, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
(b)	Address of issuer's principal executive offices: 251 Ballardvale Street, Wilmington, Massachusetts, 01887
Item 2.
(a)	Name of person filing: Nomura Holdings, Inc.
(b)	Address or principal business office or, if none, residence: Nomura Holdings, Inc.: 13-1, Nihonbashi 1-chome, Chuo-ku, Tokyo 103-8645, Japan
(c)	Citizenship: Nomura Holdings, Inc.: Japan
(d)	Title of class of securities: Common Stock, $0.01 par value per share
(e)	CUSIP No.: 159864107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Items 5-11 of the cover page are incorporated by reference.
(b)	Percent of class: Items 5-11 of the cover page are incorporated by reference.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Items 5-11 of the cover page are incorporated by reference.
	(ii) Shared power to vote or to direct the vote: Items 5-11 of the cover page are incorporated by reference.
	(iii) Sole power to dispose or to direct the disposition of: Items 5-11 of the cover page are incorporated by reference.
	(iv) Shared power to dispose or to direct the disposition of: Items 5-11 of the cover page are incorporated by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit B
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

NOMURA HOLDINGS INC

Signature:	/s/ Samir Patel
Name/Title:	Samir Patel, Managing Director
Date:	08/14/2025

Exhibit Information

Exhibit A - Subsidiaries